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Physico-chemical characteristicsTo obtain insight in translocation of nanoparticles across the placental barrier, translocation was studied
for one positively and two negatively charged polystyrene nanoparticles (PS-NPs) of similar size in an
in vitro model. The model consisted of BeWo b30 cells, derived from a human choriocarcinoma grown
on a transwell insert forming a cell layer that separates an apical from a basolateral compartment.
PS-NPs were characterized with respect to size, surface charge, morphology and protein corona.
Translocation of PS-NPs was not related to PS-NP charge. Two PS-NPs were translocated across the
BeWo transwell model to a lower extent than amoxicillin, a model compound known to be translocated
over the placental barrier to only a limited extent, whereas one PS-NP showed a slightly higher
translocation. Studies on the effect of transporter inhibitors on the translocation of the PS-NPs indicated
that their translocation was not mediated by known transporters and mainly dependent on passive
diffusion. It is concluded that the BeWo b30 model can be used as an efﬁcient method to get an initial
qualitative impression about the capacity of NPs to translocate across the placental barrier and set
priorities in further in vivo studies on translocation of NPs to the fetus.
 2015 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Nanoparticles (NPs) are incorporated in a variety of consumer
products, such as electronics, clothing, food, cosmetics and medi-
cines. Consequently, there is an increasing potential for workers
and consumers to be exposed to various NPs. Due to their small size
and relatively large surface area compared to volume, NPs have
physico-chemical characteristics different from the bulk material
(Auffan et al., 2009). Although these novel characteristics drive
the development of numerous applications in many ﬁelds of tech-
nology and medicine, they may also have unforeseen (adverse)
health effects (Oberdorster, 2004; Stampﬂ et al., 2011). It is known
that size and surface functionalization are major factors that inﬂu-
ence kinetics, including rate of uptake, distribution, and excretion
of NPs, and thereby their possible toxicity (Bhattacharjee et al.,
2013a; Oberdorster et al., 2005; Park et al., 2011; Sager and
Castranova, 2009). In order to bypass in vivo toxicity testing of
every type of NP, efﬁcient in vitro research methods withprognostic potential would be of great value. Therefore, suitable
in vitro methods are needed that can be used to predict the
in vivo kinetics of NPs in order to predict in vivo internal exposure.
At present, research on transplacental transfer of nanomaterials
and their effects on the placenta and the developing fetus is still
in its infancy (Buerki-Thurnherr et al., 2012; Juch et al., 2013;
Saunders, 2009). However, the fetus may be exposed to NPs upon
translocation across the placenta, (Menjoge et al., 2011). The aim
of the present study was to obtain insight in translocation of NPs
across the placental barrier by studying translocation of positively
and negatively charged polystyrene NPs (PS-NPs) across an
in vitromodel. Themodel consisted of BeWo b30 cells, derived from
a human choriocarcinoma, grown on a transwell insert forming a
cell layer that separates an apical compartment from a basolateral
compartment. When grown on transwell inserts, BeWo b30 cells
retain functional adenosine triphosphate binding cassette (ABC)
transporters speciﬁc to the apical and basolateral membranes, such
as P-glycoprotein (Pgp), breast cancer resistance protein (BCRP) or
multidrug resistance-associated protein 1 (MRP-1) (Atkinson
et al., 2003; Ceckova et al., 2006; Evseenko et al., 2006;
Milane et al., 2009; Mitra and Audus, 2010; Utoguchi et al., 2000;
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entiation markers, such as human chorionic gonadotrophin (HCG)
(Takeuchi et al., 1990) and the major cytochrome P450 isoforms
(CYP1A1 and 1A2) present in placenta (Avery et al., 2003). In our
previous studies the BeWo b30 transwell model was shown to be
useful to study placental translocation of drugs and nutrients, and
translocation of these compounds across the BeWo b30 layer in
the transwell model appeared to correlate with their translocation
in an ex vivo human placental model (Li et al., 2013). In the present
study the BeWo b30 transwell model was used to study possible
placental translocation of NPs. The model NPs selected for this
study were 50 nm PS-NPs with positive or negative charge.
PS-NPs are used in various products like food packaging, drug deliv-
ery systems, sensors, paints and electronics spacers in LCD displays
(Arora and Padua, 2010; Chiu et al., 2015; Lee et al., 2014;
Phosphorex; Simon et al., 2008). PS-NPs were characterized by
measuring their size and polydispersity index (PDI) by dynamic
light scattering (DLS), their surface potential (as an indication of
surface charge) by f-potential measurements, their protein corona
by SDS–PAGE and their morphology by scanning electron
microscopy (SEM).2. Materials and methods
2.1. Chemicals
Fluorescent red PS-NPs were obtained fromMagsphere Inc. (Cat
nr: AMFR050NM, CAFR050NM). Fluorescent Yellow-Green car-
boxylated 50 nm microspheres were obtained from Polysciences
(Cat nr. 16661-10). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetr
azolium bromide (MTT), ﬂuorescein, antipyrine, amoxicillin,
b-mercaptoethanol and Dulbecco’s modiﬁed Eagle’s medium
(DMEM) (Cat nr. D5071 and D5671) were purchased from
Sigma–Aldrich (Zwijndrecht, The Netherlands). Penicillin–strepto
mycin, L-glutamine, trypsin–EDTA, fetal calf serum (FCS),
phosphate-buffered saline (PBS), and Hank’s balanced salt solution
(HBSS) were obtained from Invitrogen (Breda, The Netherlands).
Laemmli Sample Buffer, Precision Plus Protein Dual Color
Standards marker, Bio-Safe Coomassie Stain G-250 and
Mini-PROTEAN TGX Gels were obtained from Bio-rad
(Veenendaal, The Netherlands).
2.2. Cell culture
The choriocarcinoma BeWo cell line (clone b30) was kindly pro-
vided by the Institute of Public Health of the Faculty of Health
Sciences (University of Copenhagen, Denmark) with permission
from Dr. Alan Schwartz (Washington University, St. Louis, MO)
and conﬁrmed to be mycoplasma negative. Cells were cultured at
37 C with 5% CO2 in a humidiﬁed atmosphere in DMEM
supplemented with 10% (v/v) heat inactivated FCS, 1% (v/v)
penicillin–streptomycin and 1% (v/v) L-glutamine. Cells were
subcultured every 3–4 days when reaching 80% conﬂuency using
trypsin–EDTA after rinsing with PBS.
2.3. Particle characterization
The size (hydrodynamic diameter) of the PS-NPs was deter-
mined by dynamic light scattering (DLS) using a Cobolt Samba
300 mW DPSS laser at a wavelength of 532 nm as a light source.
Measurements were performed on freshly prepared NP solutions
at 10 lg/ml in nanopure water and in cell culture medium contain-
ing 10% FCS. For each sample, twenty measurements were made
and the detector intensity data (measured with an ALV/SO SIPD
Single Photon Detector with ALV Static and Dynamic Fiber optics)were processed with an ALV5000/60X0 external correlator and
ALV-5000/E software (all from ALV-GmbH, Germany). Data were
analyzed with the AfterALV software and mean diameter and poly-
dispersity index (PDI) were determined for each PS-NP sample.
Additionally the f-potential of the PS-NPs was measured at a con-
centration of 100 lg/ml using the Malvern Zetasizer 2000 (Malvern
Instruments, UK). Three independent measurements, each
containing 5 sub-measurements, were used to establish the aver-
age f-potential and standard deviation (SD) for each sample.
Morphology of the PS-NPs was characterized by scanning electron
microscopy (SEM). To this end suspensions of the PS-NPs
(20 lg/ml) in water were studied using SEM. Of each suspension
20 ll was deposited on a nickel-coated polycarbonate ﬁlter, which
was mounted on an aluminum specimen holder. The droplets were
left to dry. Subsequently the ﬁlters with PS-NPs were coated with a
5 nm layer of chromium with an Emitech K575X turbo sputter
coater. The high resolution ﬁeld emission gun scanning electron
microscope (FEG-SEM) used in this study was a Tescan
MIRA-LMH FEG-SEM (Tescan, Brno, Czech Republic). The micro-
scope was operated at an accelerating voltage of 15 kV, working
distance (WD) of 10 mm and spot size of 5 nm. The mean diameter
±SD of 50–500 particles is given.
2.4. Protein corona detection
For the protein corona characterization, methods were adapted
from previous similar studies (Lesniak et al., 2010; Lundqvist et al.,
2008). Brieﬂy, PS-NPs were suspended in DMEM cell culture med-
ium containing 10% FCS at a concentration of 1.66 mg/ml and incu-
bated for 24 h at 37 C. The samples were centrifuged 40 min at
18,000 rcf at 15 C to pellet the NP-protein complexes. The pellet
was resuspended in 1 ml PBS, transferred to a new tube and cen-
trifuged again. This washing procedure was repeated three times
to eliminate non-ﬁrmly bound proteins, using a new tube in every
wash step to avoid artifacts from proteins bound to the tube wall.
Finally, after the last centrifugation, the supernatant was removed
and the pellets were resuspended carefully with 70 ll of a 1:1 (v/v)
mixture of PBS and 2 Laemmli Sample Buffer containing 5%
b-mercaptoethanol. Next, the samples were boiled for 5 min at
98 C to denature the proteins and unbind the proteins from the
PS-NPs and then cooled down immediately on ice. Samples were
again centrifuged 40 min at 18,000 rcf at 15 C to separate the
PS-NPs from proteins desorbed from their surface. Of the super-
natant containing the desorbed proteins 20 ll was loaded on the
gel. In this way the amount of protein loaded in each lane was nor-
malized for the weight of the different PS-NPs in the sample. A sec-
ond gel was loaded with samples that were normalized for amount
of protein in each lane. As we could not measure the protein con-
tent because of interference of b-mercaptoethanol which was pre-
sent and required in all samples, an indirect measurement of total
protein present in the samples was used. To this end the acquired
gel image of the ﬁrst gel was digitally analyzed for the pixel inten-
sity of each whole lane. We thus obtained an estimate of the
amount of protein loaded in each sample. The pixel intensity of
all lanes was expressed relative to the pixel intensity of the lane
with the lowest pixel intensity. This resulted in a factor by which
the samples should be diluted in order to load the same amount
of protein in all lanes of the second gel. One-dimensional polyacry-
lamide gel electrophoresis was performed using standard methods
on the Bio-RadMini-Protean system, at 90 V for about 80 min, until
the proteins neared the end of the gel (Mini-PROTEAN TGX Gel,
12% polyacrylamide 1 mm). A marker sample was included on each
gel. The gels were washed in 40% methanol in water containing
10% acetic acid for 15 min and subsequently stained with
Bio-Safe Coomassie Stain G-250 for 1.5 h. Afterward, the gels were
washed extensively and stored overnight in distilled water. Gels
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and analyzed by further quantiﬁcation of the band intensity of
the lanes with the Odyssey software (Li-cor Biosciences).
Experiments were repeated three times.
2.5. MTT assay
BeWo b30 cells were seeded at 1  104 cells/well in 100 ll cul-
ture medium in 96-well plates and incubated at 37 C and 5% CO2
for 24 h, followed by exposure to 100 ll of PS-NP solutions with
concentrations ranging from 0 lg/ml to 100 lg/ml. After 24 h
10 ll of MTT solution in PBS (5 mg/ml) was added to the medium
to reach a ﬁnal concentration of 0.5 mg/ml MTT. After 1.5 h incuba-
tion, the MTT solution was removed and 100 ll/well pure DMSO
were added to lyse the cells and to dissolve the formazan crystals.
The plates were shaken for 10 min protected from light and subse-
quently absorbance was measured at 562 and 620 (background)
nm using a SpectraMax M2 Microplate Reader (Molecular
Devices LLC, Sunnyvale, CA USA). For each PS-NP concentration cel-
lular MTT reduction to formazan is expressed as percentage of the
corresponding DMEM control reading (0 lg/ml). The absence of
possible interference of particle ﬂuorescence with the absorbance
readings was conﬁrmed by reading the absorbance of wells with
different concentrations of NPs after adding MTT and this indicated
there was no interference of the particles with the absorbance
readings.
2.6. Translocation studies
Originally transwell membranes are coated with placental col-
lagen before seeding the BeWo b30 cells (Bode et al., 2006).
However, previous studies showed that this collagen coating inhi-
bits NP transfer across the permeable membrane (Cartwright et al.,
2012). Therefore, no collagen coating was used in the translocation
studies. This will present a model presenting the highest possible
translocation and thus preventing underestimation of the
translocation. BeWo b30 cells were seeded at a density of
100,000 cells/cm2 on 12-well transwell inserts containing a poly-
carbonate membrane (0.4 lm pore size and a surface area of
1.12 cm2) (Corning, NY, product number 3401) with daily refresh-
ment of the medium as described by (Poulsen et al., 2009). At day 6
post-seeding the BeWo b30 cell layers were washed twice with
prewarmed (37 C) HBSS without phenol red after which transep-
ithelial electrical resistance (TEER) measurements were performed
just before exposure using a Millicell ERS-2 Volt-Ohm Meter
(Millipore, USA). Cell layers showing TEER values >160 ohm cm2
were chosen for translocation experiments, as these were values
reported by others indicating a intact barrier (Li et al., 2013; Liu
et al., 1997). After TEER measurement, HBSS was removed and
replaced by exposure medium.
Translocation of the two reference compounds amoxicillin and
antipyrine (both at ﬁnal concentration 100 lM) was assessed by
adding apically 0.5 ml of the test compound dissolved in HBSS
and basolaterally 1.5 ml of HBSS. In order to ensure the quality of
the BeWo model, we always include both antipyrine and amoxi-
cillin in our transport studies, using the circumstances (HBSS with-
out protein) as used in our validation study (Li et al., 2013). In that
study, (Li et al., 2013) showed that the transport of antipyrine and
amoxicillin is not affected by the presence of proteins in the med-
ium. At selected time points a sample of 0.2 ml was taken from the
basolateral compartment and replaced by an equal volume of
HBSS. At the end of each experiment 0.2 ml was also taken from
the apical compartment. Subsequently cells were washed three
times with HBSS without phenol red, TEER values were determined
to check for an intact barrier. If the TEER value after the transloca-
tion study was not lower than before the translocation study, theexperiment was considered valid, and the membrane with cells
was dissected and transferred to an Eppendorf tube containing
250 ll 65% (v/v) methanol to determine the amount of compound
accumulated in the cells using HPLC.
Translocation of PS-NPs in time was tested by adding 0.5 ml of
the freshly prepared vortexed PS-NP dilutions in phenol red free
DMEM supplemented with 10% FCS to the apical compartment.
At selected time points, samples of 100 ll were taken from the api-
cal and basolateral compartments and at the end of the incubation
the membranes with BeWo b30 cell layers were washed three
times with HBSS (37 C) without phenol red and TEER values were
measured to check cell layer integrity. Then membranes were
dissected and transferred to an Eppendorf tube containing 400 ll
cold nanopure water. Samples were sonicated in order to lyse the
cells and samples of 100 ll were taken and added to a 96 wells
plate to measure ﬂuorescence for PS-NP quantiﬁcation. PS-NP
quantiﬁcation was done by ﬂuorescence measurements using a
calibration curve (Magsphere PS-NPs: kex = 540, kem = 630,
Polysciences PS-NPs kex = 485, kem = 530) using a SpectraMax M2
Microplate Reader (Molecular Devices LLC, Sunnyvale, CA USA).
The role of speciﬁc transporters in the translocation of PS-NPs
was tested by performing the translocation experiments in the
presence or absence of the transporter inhibitors verapamil
(inhibitor of PgP), KO143 (inhibitor of human breast cancer
resistance protein; BCRP), MK571 (inhibitor of multidrug
resistance-associated protein 1; MRP-1), chlorpromazine (inhibitor
of caveolin-mediated endocytosis) or methyl-b-cyclodextrin
(MbCD) (inhibitor of clathrin-mediated endocytosis). Table S1 pre-
sents an overview of the different transporter inhibitors used, their
transporter speciﬁcity, their concentrations generally used in liter-
ature to study transporter inhibition and relevant references
Bhattacharjee et al. (2013b), Brand et al. (2008), dos Santos et al.
(2011), Ushigome et al. (2000), Ceckova et al. (2006). All inhibitors
were diluted from a 250 times concentrated stock solution in DMSO
in cell culture medium, except for MbCD which was diluted from a
250 times concentrated stock solution in PBS. Transporter inhibi-
tors were also added to the basolateral compartment containing
1.5 ml culture medium, using the same concentrations as applied
in the apical compartment. Subsequently, the plate was incubated
in a humidiﬁed atmosphere with 5% CO2 at 37 C. After 24 h, sam-
ples of 100 ll were taken and PS-NPs were quantiﬁed by ﬂuores-
cence measurements in the same way as previously described.
2.7. High performance liquid chromatography analysis
To determine the transport rate of amoxicillin and antipyrine,
the collected samples were quantiﬁed using High Performance
Liquid Chromatography (HPLC) as was described by (Li et al., 2013).
2.8. Data analysis
The apparent permeability coefﬁcients (Papp; cm/s) were calcu-
lated according to:
Papp ¼ ðdQ=dtÞ=ðA C0Þ
In which dQ/dt is the transport velocity (nmol/s or lg/s) in the
initial phase when appearance in the basolateral chamber is linear
in time, A – the surface area of the membrane insert (cm2) and C0
the initial concentration of the compound in the donor chamber
(nmol/ml or lg/ml) (Artursson and Karlsson, 1991).
2.9. Statistical analysis
Each experiment was repeated at least three or four times and
the results are shown as mean ± standard deviation (SD).
Statistical analyses were performed using GraphPad Prism
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post hoc Tukey test to determine signiﬁcant differences between
the groups. Groups were considered signiﬁcantly different when
p < 0.05.3. Results
3.1. Physico-chemical characterization of the PS-NPs
This study included three types of PS-NPs, one 50 nm positively
charged PS-NP and two 50 nm negatively charged PS-NPs. The two
50 nm negatively charged PS-NPs were included because previous
studies of our group revealed that these are translocated to a dif-
ferent extent across a Caco-2 monolayer (Walczak et al., 2014).
Several physico-chemical properties of the nanoparticles were
characterized.
SEM pictures of the PS-NPs (Fig. 1) conﬁrm the spherical shape
of the particles and their diameter of around 50 nm, although
smaller particles can be observed in all samples. Automatic diam-
eter measurements of these desiccated PS-NPs show that their
sizes range between 15 and 75 nm with a mean value at
31.6 nm, 35 nm and 50.6 nm for the negatively chargedFig. 1. SEM pictures of (A) 50 nm negatively charged PS-NP (Polysciences), (B) 50 nm
(Magsphere).(Polysciences), negatively charged (Magsphere) and positively
charged (Magsphere) PS-NPs respectively (Table S2).
The hydrodynamic diameters of the hydrated NPs were mea-
sured by dynamic light scattering (DLS) in nanopure water and
in the culture medium containing 10% FCS as used for the translo-
cation experiments (Table 1). The measured sizes of the PS-NPs in
nanopure water were close to the sizes reported by the manufac-
turer. Upon addition of the positively charged PS-NPs to DMEM
with 10% FCS, their size increased 1.5-fold. The measured sizes of
the negatively charged PS-NPs (Magsphere) and negatively
charged PS-NPs (Polysciences) in DMEM with 10% FCS increased
slightly by 1.4 and 1.1 fold, respectively (Table 1). It is of interest
to note that DLS analysis of medium with 10% FCS alone revealed
that proteins from the FCS appear to form particles of comparable
sizes as the NPs (Fig. S1). Formation of protein complexes in the nm
range have been reported before (Liu et al., 2013a). Thus, DLS mea-
surements of NPs in medium containing 10% FCS may be hampered
by the protein aggregates of comparable size.
The surface charges of the positively and negatively charged
PS-NPs were measured in nanopure water and in DMEM with
10% FCS by determining the zeta potential (Table 2). Positively
charged PS-NPs had a zeta potential of +51.0 mV in nanopure
water. Negatively charged PS-NPs of Magsphere and Polysciencesnegatively charged PS-NP (Magsphere) and (C) 50 nm positively charged PS-NP
Table 1
DLS data of 50 nm PS-NPs with positive or negative charge in nanopure water and in medium with 10% FCS.
Nanoparticle Medium Mean size in nm (SD) Polydispersity index (PDI)
50 nm positively charged PS-NP (Magsphere) Nanopure water 56.5 (3.02) 0.09
DMEM + FCS 82.7 (30.91) 0.49
50 nm negatively charged PS-NP (Magsphere) Nanopure water 50.4 (1.74) 0.19
DMEM + FCS 69.0 (10.1) 0.49
50 nm negatively charged PS-NP (Polysciences) Nanopure water 52.4 (0.1) 0.21
DMEM + FCS 57.6 (11.7) 0.50
Table 2
Zeta potential of 50 nm PS-NPs with positive or negative charge in nanopure water and in medium with 10% FCS, and zeta potential measured with
medium with 10% FCS.
Nanoparticle Medium Mean zeta (mV) SD
50 nm positively charged PS-NP (Magsphere) Nanopure water 51 4.5
DMEM + FCS 12.0 1.2
50 nm negatively charged PS-NP (Magsphere) Nanopure water 55.5 6.7
DMEM + FCS 11.1 0.9
50 nm negatively charged PS-NP (Polysciences) Nanopure water 58.3 2.7
DMEM + FCS 10.9 0.2
None DMEM + FCS 9.16 1.3
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nanopure water. In medium with 10% FCS all NPs get a similar
slightly negative charge. This may be explained by the fact that
the majority of particles present in these samples are protein
aggregates from the 10% FCS so that the zeta potential may reﬂect
the overall charge of the protein aggregates rather than those of
the PS-NPs (Table 2). Alternatively the similar charges in the pres-
ence of FCS may be ascribed to the protein corona dominating the
overall charge.3.2. Protein corona detection
Fig. 2A shows a representative picture of the SDS–PAGE gel with
proteins desorbed from the different PS-NPs after their incubation
in medium with 10% FCS. Each lane contains the amount of protein
obtained from the same amount of PS-NP and thus, given the similar
size of the PS-NPs, presents the amount of protein desorbed from a
presumably similar surface area of the PS-NPs. Proteins desorbed
from the protein corona of NPs are present in lanes 2–4. Fig. 2B
shows a protein gel prepared to contain the same amount of protein
in each lane. The band intensities of the lanes containing NPs were
further quantiﬁed using the Odyssey software and graphs thus
obtained are also presented in Fig. 2. These results reveal differences
in the amount but not the nature of the proteins in the corona of the
three different PS-NPs (Fig. 2A + B lanes 2–4). From the 50 nm pos-
itively charged PS-NPs (lane 3) only a small amount of protein cor-
ona was obtained. The control (lane 5) shows the DMEM sample
without nanoparticles whichwas treated by the same experimental
procedure as NP samples. Hardly any protein is detected in this con-
trol, which corroborates that the proteins which are detected in the
other samples are coming from the protein corona of the PS-NPs.
Lane 6 shows the proteins present in the medium containing 10%
FCS and comparison of this pattern to that of the PS-NPs reveals that
not all medium proteins contribute to the protein corona to the
same relative extent at which they are present in the medium, indi-
cating at least some preferential binding of proteins to the NPs.3.3. Cell viability studies
Before testing the transplacental translocation of the PS-NPs,
the concentration of the PS-NPs to be tested in the BeWo b30transwell translocation studies were chosen based on results from
cell viability studies. The cell viability of BeWo b30 cells upon 24 h
exposure to increasing PS-NP concentrations was determined
using the MTT assay. Only cells exposed to the positively charged
PS-NPs showed a decrease in MTT reduction, an effect that
becomes statistically signiﬁcant at concentrations of 20 lg/ml
and higher (Fig. 3), whereas no effect was found upon exposure
to the negatively charged PS-NPs. Based on these results the con-
centration of PS-NPs to be tested in the translocation studies was
chosen at 10 lg/ml.3.4. Placental translocation of model compounds
In order to calibrate the BeWo b30 model system and provide
points for comparison the translocation of two model compounds
antipyrine and amoxicillin was determined. These compounds
are known to be translocated across the placenta and also across
the BeWo cell layer in vitro at respectively high or low rate
(Akbaraly et al., 1985; Li et al., 2013). Table 3 shows the apparent
permeability coefﬁcients for antipyrine and amoxicillin amounting
to 53  106 cm/s for antipyrine and 5.1  106 cm/s for amoxi-
cillin indicating that the translocation of these two model com-
pounds varies by one order of magnitude. Previously it was
reported that for a series of model compounds including antipyrine
and amoxicillin a good correlation (r2 = 0.95) exists between their
relative transport in the BeWo b30 transwell model and their
transport in an ex vivo placental perfusion model (Li et al., 2013)
and that also in the ex vivo placental transport model antipyrine
and amoxicillin showed a difference in transport rate of about
one order of magnitude (Akbaraly et al., 1985).3.5. Placental translocation of PS-NPs
The time-dependent translocation of the three PS-NPs to the
basolateral compartment was determined using an apical concen-
tration of 10 lg/ml PS-NP (Fig. 4). Upon 24 h incubation the nega-
tively charged PS-NPs from Magsphere were not detected in the
basolateral compartment . For the other two PS-NPs a time depen-
dent increase in the basolateral compartment was observed
(Fig. 4). The apparent permeability coefﬁcient of the positively
charged PS-NPs from Magsphere was the lowest (Papp value of
50 nm negative 
(Polysciences)




50 nm negative 
(Polysciences)






Fig. 2. SDS–PAGE gel showing the desorbed protein corona of different PS-NPs with the lanes containing: in gel (A) the amount of protein corresponding to the same surface
area of the PS-NPs and those in gel (B) a similar amount of total protein. Lanes: (1) marker; (2) 50 nm negatively charged (Magsphere); (3) 50 nm positively charged
(Magsphere); (4) 50 nm negatively charged (Polysciences); (5) Control: medium sample without NPs which followed the same experimental procedure as the NP-samples;
(6) Medium. The right part of the ﬁgure shows the banding pattern of lanes 2–4 and 6.
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PS-NPs from Polysciences (Papp value of 13  106 cm/s). In the
absence of cells, PS-NP translocation across the insert was much
higher which corroborates that the BeWo b30 cell layer acts as a
barrier.
Comparison of the apparent permeability coefﬁcients of the
PS-NPs that were translocated with that of the reference com-
pound amoxicillin, known to be translocated over the placental
barrier to only a limited extent, reveals that translocation of the
positively charged PS-NPs of Magsphere is 17 fold lower than thatof amoxicillin, whereas the translocation of the negatively charged
PS-NPs from Polysciences was 2.5 fold higher than that of amoxi-
cillin (Table 3).
3.6. Compartmental distribution of PS-NPs in the presence of
transporter inhibitors
To investigate the possible role of speciﬁc transport mecha-
nisms in the translocation of the PS-NPs across BeWo b30 cell lay-
ers, the distribution of the NPs over the three compartments
Fig. 3. Effects of three different PS-NPs on cell viability of BeWo b30 cells as
determined with the MTT assay. BeWo b30 cells were exposed for 24 h to increasing
concentrations of 50 nm positively charged PS-NP (Magsphere) (open triangle) or
50 nm negatively charged PS-NP (Magsphere) (closed circle) or 50 nm negatively
charged PS-NP (Polysciences) (open square) PS-NPs. Data are expressed as
percentage of the negative control and presented as the mean ± SD of n = 3
independent biological replicates. The ⁄ indicates p < 0.05 for a signiﬁcant difference
with the other two types of PS-NPs (n = 3).
Table 3
Apparent permeability (Papp) coefﬁcients across BeWo b30 cell barrier of the
reference compounds antipyrine and amoxicillin, and the PS-NPs. Data presented are
the mean ± SD of n = 3 independent biological replicates.
Mean Papp value ± SD
(cm/s)
Antipyrine 53  106 ± 5.6  106
Amoxicillin 5.1  106 ± 0.52  106
50 nm positively charged PS-NP (Magsphere) 0.3  106 ± 0.05  106
50 nm negatively charged PS-NP (Magsphere) *ND
50 nm negatively charged PS-NP (Polysciences) 13  106 ± 1.1  106
⁄ ND: not detected, so no Papp coefﬁcient derived.
Fig. 4. Time dependent translocation across the BeWo b30 cell layer of 50 nm
positively charged PS-NPs of Magsphere (open triangle), 50 nm negatively charged
PS-NPs of Magsphere (open square) and 50 nm negatively charged PS-NPs of
Polysciences (closed square) with starting concentration of 10 lg/ml. Papp values
(Table 3) were calculated from the linear part of the curve. Results presented are the
mean ± SD of n = 3 independent biological replicates.
S.K. Kloet et al. / Toxicology in Vitro 29 (2015) 1701–1710 1707(apical, basolateral and intracellular) was assessed in the presence
or absence of inhibitors of endocytosis or of speciﬁc ABC trans-
porters. Results obtained are presented in Fig. 5. For the positively
charged PS-NPs, the presence of MK571, an inhibitor of MRP-1,
slightly but signiﬁcantly (p < 0.01) decreased the amount of
PS-NPs in the apical compartment from 71.5% to 67.8 % andsigniﬁcantly increased (p < 0.01) the amount of PS-NPs in the baso-
lateral compartment from 7.5% to 11.5 % (Fig. 5A), indicating a 1.5
fold increased translocation across the BeWo b30 cell layer. TEER
measurements performed after the distribution studies showed
that the barrier integrity of the BeWo b30 cell layer was not
affected, indicating that the increased translocation did not result
from a compromised cell layer. Co-exposure to the positively
charged PS-NPs and the BCRP- or PgP-inhibitors KO143 and vera-
pamil, respectively, did not show an effect on the distribution of
these PS-NPs (Fig. 5A). For the negatively charged 50 nm PS-NPs
from Polysciences, none of the inhibitors showed a signiﬁcant
effect on the distribution of these particles in the BeWo transwell
model (Fig. 5B) and the lack of intracellular signal indicates no
intracellular localization. In addition, the clathrin and caveolin
inhibitors (5 lM chlorpromazine or 1 lMMbCD, respectively) used
to inhibit clathrin- and caveolin-mediated endocytosis, did not
show an effect on translocation or distribution of any of the
PS-NPs.4. Discussion
To obtain insight in passage of NPs across the placental barrier,
translocation of one positively and two different types of nega-
tively charged PS-NPs across an in vitro model of the placental bar-
rier was studied. The two negatively charged PS-NPs were included
because previous studies within our group revealed they were
translocated to a different extent across a Caco-2 monolayer, a
model for intestinal translocation (Walczak et al., 2014). The model
in the present study consisted of cells of the BeWo cell line (clone
b30) grown on a transwell insert, and forming a cell layer that sep-
arates an apical compartment from a fetal compartment.
The characterization of the PS-NPs was done by measuring the
size and polydispersity index (PDI) by dynamic light scattering
(DLS), the f-potential (as an indication of surface charge) by
f-potential measurements, the protein corona by SDS–PAGE and
shape and the number-based size distribution by scanning electron
microscopy (SEM). The results obtained reveal that in the presence
of 10% FCS in cell culture medium, measurement of f-potential
may be hampered by the presence of free protein particles as the
f-potential of medium without or with PS-NPs present, resulted
in the same negative f-potential. Alternatively the similar charges
of the differently charged NPs in the presence of FCS may be
ascribed to their protein corona dominating the underlying
PS-NP’s charge. SDS–PAGE analysis of this protein corona revealed
that there were differences in mainly the amount but not in the
nature of the proteins in the corona of the differently charged
PS-NPs. The proteins desorbed from the PS-NPs were to a large
extent a reﬂection of what was detected in the medium containing
10% FCS. This result was somewhat different from a previous study
that reported that surface properties of PS-NPs signiﬁcantly
affected the composition of the protein corona (Lundqvist et al.,
2008). In this latter study using different commercially available
PS-NPs and mass spectrometry instead of SDS–PAGE, a fraction
(about 35%) of the proteins in the corona were speciﬁcally detected
on the positively charged PS-NPs or on the negatively charged
PS-NPs, the others being similar.
In the present study it appeared that in spite of similar size
(SEM and DLS), f-potential and type of proteins in the protein coro-
na, the differently charged NPs displayed a remarkable difference
in cytotoxicity, with only the PS-NPs with an original positive
charge inducing cytotoxicity. The relatively higher cytotoxicity of
positively as compared to negatively charged NPs was reported
before for tri-block copolymer NPs (Bhattacharjee et al., 2012)
but also for other type of NPs like gold NPs (Liu et al., 2013b)
and silicon NPs (Bhattacharjee et al., 2013a). Thus for interaction
Fig. 5. Effect of speciﬁc transporter inhibitors (Table S1) on the distribution of (A) 50 nm positively charged PS-NPs of Magsphere; (B) 50 nm negatively charged PS-NP of
Polysciences in the BeWo transwell model, 24 h after adding 0.5 ml of a 10 lg/ml PS-NP solution to the apical compartment. Results presented are the mean ± SD of n = 4
independent biological replicates. The ⁄ indicates a difference (p < 0.01) compared to the situation without inhibitors.
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istry of the particles as prepared and measured in water, is appar-
ently still of inﬂuence. The higher cytotoxicity of positive NPs
might be due to a stronger interaction with cells compared with
negative NPs, because of the electrostatic attraction toward the
negatively charged cell membrane (Kim et al., 2009).
Translocation of the different PS-NPs across the BeWo cell layer
was not found to be related to PS-NP charge. A remarkabledifference in translocation was found between the two 50 nm neg-
atively charged PS-NPs from different manufacturers. For the
PS-NPs from Polysciences, the apparent permeability coefﬁcient
was slightly higher than that of amoxicillin, with a Papp value of
13  106 cm/s (Table 3). When testing the negatively charged
PS-NPs from Magsphere, no PS-NPs could be detected in the baso-
lateral compartment upon adding a concentration of 10 lg/ml in
the apical compartment and 24 h incubation. A 30-fold difference
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PS-NPs across a Caco-2 monolayer in a similar transwell model
system (Walczak et al., 2014). Since none of the characterized
parameters, including size, f-potential and protein corona revealed
remarkable differences between the two negatively charged NPs,
the difference may originate from the chemical groups on the sur-
face of the NPs generating the negative charge. Although both
PS-NPs are reported by the respective manufacturers to contain
carboxylic groups from vinylic co-monomers, including acrylic
acid, methacrylic acid and itaconic acid, further details on the
chemical characteristics of the NP surface remained unknown. In
this respect it is of interest that variation in steric shielding of
the charge on a surface moiety due to subtle differences in the
chemical structure of the charge bearing moiety may affect the cel-
lular uptake and toxicity of ﬂuorescent tri-block copolymer
nanoparticles (Bhattacharjee et al., 2011). In this previous study
it was demonstrated that three different positively charged
tri-block copolymer nanoparticles showed different cellular uptake
and toxicity in spite of a similar overall size and f-potential, and
that only a different shielding of the charge due to subtle differ-
ences in the charge generating surface moiety inﬂuenced the cellu-
lar uptake and toxicity (Bhattacharjee et al., 2011). This factor may
explain the different translocation rates of the two negatively
charged 50 nm PS-NPs in this study, given the different carboxylic
groups that have been used in the production of these different
PS-NPs.
The translocation studies presented in this study revealed that
the PS-NPs were translocated across the BeWo b30 transwell
model to only a limited extent. We compared these results to
reports in the literature studying the translocation of NPs across
the placental barrier. A few studies also applied the BeWo b30
transwell model studying translocation of PEGylated gold NPs of
10–30 nm (Myllynen et al., 2008), iron oxide and silica NPs of
23–38 nm (Correia Carreira et al., 2013), dexamethasone loaded
PLGA NPs of 140–289 nm (Ali et al., 2013), rhodamine labeled silica
NPs of 25 and 50 nm (Sonnegaard Poulsen et al., 2013) and poly-
styrene NPs of 50 and 100 nm (Cartwright et al., 2012). These stud-
ies generally report that the NPs are translocated across the BeWo
cell layer after a few hours of incubation to the basolateral com-
partment albeit in relatively small amounts. The results of the pre-
sent study are in line with these observations, and suggest that
translocation of NPs across the in vitro placental barrier cannot
be excluded. Literature data obtained in ex vivo human placental
perfusion models also report the potential of NPs to cross the pla-
cental barrier (Grafmuller et al., 2013; Menjoge et al., 2011;
Sonnegaard Poulsen et al., 2013; Wick et al., 2010) and are in line
with this conclusion.
In order to investigate the role of speciﬁc transporters in the
translocation of the PS-NPs across the BeWo b30 cell layer, translo-
cation studies were also performed in the absence and presence of
transporter inhibitors. The presence of PgP, BCRP, MRP-1 has been
conﬁrmed in the BeWo b30 cells (Atkinson et al., 2003; Ceckova
et al., 2006; Evseenko et al., 2006; Milane et al., 2009; Mitra and
Audus, 2010; Wick et al., 2010) but inhibitors of PgP and BCRP at
a concentration of 50 and 2.5 lM, respectively, showed no effect
on translocation of PS-NPs across the BeWo b30 cell layers.
MK571 (24 lM), an inhibitor of MRP-1, signiﬁcantly increased
the basolateral translocation of positively charged PS-NP by 1.5
fold but did not inﬂuence the translocation of the negatively
charged PS-NPs so in general the translocation of the PS-NPs tested
appeared to occur preferentially by passive diffusion.
In vitro models are attractive for high throughput testing of var-
ious NPs. However, it should be kept in mind that in vitro models
like the BeWo b30 transwell model applied in the current study
have their limitations (Nikitina et al., 2013). For example, given
that the physiology of the placental barrier in vivo varies in time,it is difﬁcult to classify the BeWo cell layer in a representing speci-
ﬁc stage of pregnancy. Furthermore, the BeWo transwell model is a
simpliﬁed placental barrier compared to the complex in vivo pla-
cental barrier since it lacks the multiple layers of different cell
types (cytotrophoblasts and syncytiotrophoblasts) and extracellu-
lar matrix including collagen, known to constitute the in vivo pla-
cental barrier. This implies that extrapolation of in vitro results to
the in vivo situation should acknowledge uncertainties in the pre-
dictions made (Mathiesen et al., 2014). To this end we have
included the model compounds amoxicillin and antipyrine, known
to be translocated across the placental barrier to respectively only
a limited or large extent (Akbaraly et al., 1985; Li et al., 2013) to
enable qualitative interpretation of the results. This comparison
revealed that for positively charged PS-NPs translocation was 17
fold lower and for negatively charged PS-NPs from Polysciences
2.5 fold higher than that of amoxicillin, while for the negatively
charged PS-NPs from Magsphere no translocation was found under
the same test conditions.
In conclusion, the translocation studies of PS-NPs in the present
study and the comparison of the data with translocation data of
model compounds, for which the model has been validated with
an ex vivo placental model, reveal that the in vitro BeWo b30
model can be used as a fast method to get an initial qualitative
impression about the capacity of NPs to translocate across the pla-
cental barrier and set priorities for further in vivo studies on
translocation of NPs to the fetus.
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